Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Each patient starts with a subcutaneous injection of a lower dose once a week for four weeks in the abdomen, upper arm, or thigh
Epithalon does not appear to affect telomerase in transformed (cancer) cells, which already express constitutive telomerase activity, though this observation requires further investigation
JCO Oncology Practice, 10.1200/OP-26-00485
Ans: Yes, to some extent
Khanna A, John F, Das S, et al
G.AndrikopoulosS.et al (2019)
US$ 26.55
US$ 20.11
US$ 23.14
